Clinical Trials Logo

Endometrial Cancer clinical trials

View clinical trials related to Endometrial Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03322176 Enrolling by invitation - Colon Cancer Clinical Trials

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Start date: October 17, 2017
Phase:
Study type: Observational

Increase surveillance for LYNCH Syndrome

NCT ID: NCT02990728 Enrolling by invitation - Endometrial Cancer Clinical Trials

Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer

Start date: March 2016
Phase: Phase 2
Study type: Interventional

Primary objective To discover the efficacies of levonorgestrel-containing intrauterine device (LNG-IUS, Mirena®), with or without metformin, as fertility-preserving treatment for grade 1 endometrioid adenocarcinoma of endometrium, cT1aN0M0 with presumed no myometrial invasion on image study (MRI preferred). Secondary objectives 1. To discover the morphological and molecular change in the endometrium tumor before and after treatment 2. To discover the effectiveness of adding oral progestin to subjects who show no good response to assigned 3. To compare (1) the systemic effects, including body weight change, neuropsychiatric alternation, GI disturbance, skin disorder, change in serum metabolic and hepatic markers between the two study patient groups; (2) The rate of long-term success defined as (a) sustained remission of >= 12 months starts from the histologic documentation of complete remission (b) rate of pregnancy and (c) alive baby delivery, based on time-to-event analysis. 4. Molecular markers and their expression before, during and after treatment, including progesterone B receptor, progesterone A receptor, estrogen receptor, Ki67, PTEN and its related markers, Bcl2 and its related markers and other developing markers. This is to discover prediction markers to medical treatment.

NCT ID: NCT02368067 Enrolling by invitation - Clinical trials for Endometrial Carcinoma

Improved Method of Detecting Cancer Metastases

SITs
Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the Instillation Technique Using The Modified Intra- Uterine Manipulator Catheter With Methylene Blue, Isosulfan Blue or Indocyanine Green Dyes, Compared to Cervical Injection, For Sentinel Lymph Node Detection in Endometrial Carcinoma.